Avidity Biosciences, Inc.RNANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-307.94M
↓ 202% below average
Average (6y)
$-102.08M
Historical baseline
Range
High:$2.25M
Low:$-307.94M
CAGR
+77.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-307.94M | -149.8% |
| 2023 | $-123.29M | +11.4% |
| 2022 | $-139.09M | -41.1% |
| 2021 | $-98.55M | -157.9% |
| 2020 | $-38.21M | -1794.4% |
| 2019 | $2.25M | +123.2% |
| 2018 | $-9.70M | - |